NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novartis AG (SW: NOVN)

 
NOVN Technical Analysis
4
As on 25th Mar 2025 NOVN STOCK Price closed @ 98.05 and we RECOMMEND Buy for LONG-TERM with Stoploss of 90.78 & Strong Buy for SHORT-TERM with Stoploss of 85.49 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVNSTOCK Price

Open 98.40 Change Price %
High 99.30 1 Day -0.52 -0.53
Low 97.88 1 Week 1.70 1.76
Close 98.05 1 Month 0.10 0.10
Volume 4223428 1 Year 9.67 10.94
52 Week High 102.70 | 52 Week Low 83.23
 
SW Switzerland Most Active Stocks
CSGN 0.82 0.00%
CSGN 0.82 0.00%
UBSG 29.59 1.72%
UBSG 29.59 1.72%
NESN 88.84 -0.85%
NESN 88.84 -0.85%
NOVN 98.05 -0.53%
NOVN 98.05 -0.53%
ABBN 49.61 -0.78%
ABBN 49.61 -0.78%
 
SW Switzerland Top Gainers Stocks
PRFN 0.03 50.00%
PRFN 0.03 50.00%
CADN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
GAM 0.11 10.00%
GAM 0.11 10.00%
GAM 0.11 10.00%
 
SW Switzerland Top Losers Stocks
AIRE 0.09 -25.00%
AIRE 0.09 -25.00%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
 
 
NOVN
Daily Charts
NOVN
Intraday Charts
Whats New @
Bazaartrend
NOVN
Free Analysis
 
NOVN Important Levels Intraday
RESISTANCE100.79
RESISTANCE99.91
RESISTANCE99.37
RESISTANCE98.82
SUPPORT97.28
SUPPORT96.73
SUPPORT96.19
SUPPORT95.31
 
NOVN Forecast March 2025
4th UP Forecast106.03
3rd UP Forecast103.47
2nd UP Forecast101.89
1st UP Forecast100.31
1st DOWN Forecast95.79
2nd DOWN Forecast94.21
3rd DOWN Forecast92.63
4th DOWN Forecast90.07
 
NOVN Weekly Forecast
4th UP Forecast106.32
3rd UP Forecast103.67
2nd UP Forecast102.03
1st UP Forecast100.39
1st DOWN Forecast95.71
2nd DOWN Forecast94.07
3rd DOWN Forecast92.43
4th DOWN Forecast89.78
 
NOVN Forecast2025
4th UP Forecast136.05
3rd UP Forecast123.86
2nd UP Forecast116.33
1st UP Forecast108.8
1st DOWN Forecast87.3
2nd DOWN Forecast79.77
3rd DOWN Forecast72.24
4th DOWN Forecast60.05
 
 
NOVN Other Details
Segment EQ
Market Capital 171490852864.00
Sector Healthcare
Industry Drug Manufacturers-General
Offical website >
 
NOVN Address
NOVN
 
NOVN Latest News
 
Your Comments and Response on Novartis AG
 
NOVN Business Profile
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, established, and cardiovascular, renal and metabolism medicine products. The Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; an agreement with CureVac to manufacture COVID-19 vaccine candidate CVnCoV; a collaboration with Artios Pharma Limited to create next generation DDR cancer therapies; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Address: Lichtstrasse 35, Basel, Switzerland, 4056
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service